Panbela Therapeutics ROIC
What is the ROIC of Panbela Therapeutics?
The ROIC of Panbela Therapeutics Inc. is -389.48%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Panbela Therapeutics
What does Panbela Therapeutics do?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Companies with roic similar to Panbela Therapeutics
- Trend Innovations has ROIC of -402.87%
- Killi has ROIC of -402.49%
- Loop Insights has ROIC of -399.47%
- Bald Eagle Gold has ROIC of -398.26%
- ProMIS Neurosciences has ROIC of -395.85%
- Gpo Plus Inc has ROIC of -393.16%
- Panbela Therapeutics has ROIC of -389.48%
- Cyclo3pss has ROIC of -381.50%
- Rebel Capital 2.0 has ROIC of -381.00%
- BioCorRx has ROIC of -378.47%
- Reliq Health Technologies has ROIC of -374.96%
- Roboserver Systems has ROIC of -374.21%
- Global Wellness Strategies has ROIC of -374.18%